396 related articles for article (PubMed ID: 37431741)
1. Nano-drug delivery system: a promising approach against breast cancer.
Malik JA; Ansari JA; Ahmed S; Khan A; Ahemad N; Anwar S
Ther Deliv; 2023 May; 14(5):357-381. PubMed ID: 37431741
[TBL] [Abstract][Full Text] [Related]
2. Nano-pharmaceutical formulations for targeted drug delivery against HER2 in breast cancer.
Sadat SM; Saeidnia S; Nazarali AJ; Haddadi A
Curr Cancer Drug Targets; 2015; 15(1):71-86. PubMed ID: 25564255
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles in pancreatic cancer therapy: a detailed and elaborated review on patent literature.
Singh M; Jana BK; Pal P; Singha I; Rajkumari A; Chowrasia P; Nath V; Mazumder B
Expert Opin Ther Pat; 2023 Oct; 33(10):681-699. PubMed ID: 37991186
[TBL] [Abstract][Full Text] [Related]
4. Opportunities in combinational chemo-immunotherapy for breast cancer using nanotechnology: an emerging landscape.
Raikwar S; Jain A; Saraf S; Bidla PD; Panda PK; Tiwari A; Verma A; Jain SK
Expert Opin Drug Deliv; 2022 Mar; 19(3):247-268. PubMed ID: 35184620
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple- Negative Breast Cancer (TNBC).
Kanugo A; Gautam RK; Kamal MA
Curr Pharm Biotechnol; 2022; 23(13):1581-1595. PubMed ID: 34967294
[TBL] [Abstract][Full Text] [Related]
6. Combinational drug delivery using nanocarriers for breast cancer treatments: A review.
Olov N; Bagheri-Khoulenjani S; Mirzadeh H
J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607
[TBL] [Abstract][Full Text] [Related]
7. Polymeric Nanocarriers: A New Horizon for the Effective Management of Breast Cancer.
Khan I; Kumar H; Mishra G; Gothwal A; Kesharwani P; Gupta U
Curr Pharm Des; 2017; 23(35):5315-5326. PubMed ID: 28875848
[TBL] [Abstract][Full Text] [Related]
8. The new era of nanotechnology, an alternative to change cancer treatment.
Jurj A; Braicu C; Pop LA; Tomuleasa C; Gherman CD; Berindan-Neagoe I
Drug Des Devel Ther; 2017; 11():2871-2890. PubMed ID: 29033548
[TBL] [Abstract][Full Text] [Related]
9. Nanocarriers for diagnosis and targeting of breast cancer.
Sharma A; Jain N; Sareen R
Biomed Res Int; 2013; 2013():960821. PubMed ID: 23865076
[TBL] [Abstract][Full Text] [Related]
10. Nanotherapeutics for the Treatment of Cancer and Arthritis.
Patel P; Meghani N; Kansara K; Kumar A
Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
[TBL] [Abstract][Full Text] [Related]
11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
12. Nano drug-delivery systems for management of AIDS: liposomes, dendrimers, gold and silver nanoparticles.
Asl FD; Mousazadeh M; Taji S; Bahmani A; Khashayar P; Azimzadeh M; Mostafavi E
Nanomedicine (Lond); 2023 Feb; 18(3):279-302. PubMed ID: 37125616
[TBL] [Abstract][Full Text] [Related]
13. Managing Apoptosis in Lung Diseases using Nano-assisted Drug Delivery System.
Shukla MK; Dubey A; Pandey S; Singh SK; Gupta G; Prasher P; Chellappan DK; Oliver BG; Kumar D; Dua K
Curr Pharm Des; 2022; 28(39):3202-3211. PubMed ID: 35422206
[TBL] [Abstract][Full Text] [Related]
14. Nano-based drug delivery system for therapeutics: a comprehensive review.
Prakash S
Biomed Phys Eng Express; 2023 Aug; 9(5):. PubMed ID: 37549657
[TBL] [Abstract][Full Text] [Related]
15. Drug Delivery of Natural Products Through Nanocarriers for Effective Breast Cancer Therapy: A Comprehensive Review of Literature.
Yap KM; Sekar M; Fuloria S; Wu YS; Gan SH; Mat Rani NNI; Subramaniyan V; Kokare C; Lum PT; Begum MY; Mani S; Meenakshi DU; Sathasivam KV; Fuloria NK
Int J Nanomedicine; 2021; 16():7891-7941. PubMed ID: 34880614
[TBL] [Abstract][Full Text] [Related]
16. Cancer nanotechnology: application of nanotechnology in cancer therapy.
Misra R; Acharya S; Sahoo SK
Drug Discov Today; 2010 Oct; 15(19-20):842-50. PubMed ID: 20727417
[TBL] [Abstract][Full Text] [Related]
17. Unique roles of nanotechnology in medicine and cancer-II.
Alam F; Naim M; Aziz M; Yadav N
Indian J Cancer; 2015; 52(1):1-9. PubMed ID: 26837958
[TBL] [Abstract][Full Text] [Related]
18. Phytofabricated Nanoparticle Formulation for Cancer Treatment: A Comprehensive Review.
Verma M; Fatima S; Ansari IA
Curr Drug Metab; 2022; 23(10):818-826. PubMed ID: 35490313
[TBL] [Abstract][Full Text] [Related]
19. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
20. Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer.
Gupta U; Saren BN; Khaparkhuntikar K; Madan J; Singh PK
J Control Release; 2022 Aug; 348():1089-1115. PubMed ID: 35640765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
